journal article·2017-10-11

Substance P Mediated DGLs Complexing with DACHPt for Targeting Therapy of Glioma

Tao Sun, Xutao Jiang, Qingbing Wang, Qinjun Chen, Yifei Lu, Lisha Liu, Yu Zhang, Xi He, Chunhui Ruan, Yujie Zhang, Qin Guo, Yaohua Liu, Chen Jiang

Publisher page

Abstract

Currently, glioblastoma (glioma) is described as the deadliest brain tumor for its invasive natural with exceeding difficulty in surgical excision. Blood-brain barrier (BBB) can restrict the penetration of most therapeutic reagents including platinum (Pt)-based drugs-the most widely used reagents in clinical trials for their revolutionized cancer chemotherapy against a broad range of tumors. Nanomedicine represents a promising strategy for the intravenous delivery of Pt-based drugs into the brain. In this research, with the aim of malignant glioma treatment by Pt-based drugs, a novel nano drug carrier was developed: dendrigraft poly-L-lysines (DGLs) was PEGylated, linked with diethylenetriaminpentaacetic acid (DTPA) to complex (1,2-diaminocyclohexane)platinum(II) (DACHPt), and modified with Substance P (SP) as a BBB/glioma dual-targeting moiety. The preparation and characterization of the platform were exhibited in detail. The increased targeting capability and antitumor effect was found both in vitro and in vivo. The well-defined chemical composition, rigorously nanoscaled size and the first attempt of using SP as a BBB/glioma dual-targeting group were highlighted. The combined results suggest this strategy may serve as novel formulation for Pt-based drugs with the aim of clinical glioma treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · Nanoparticle-Based Drug Delivery · Metal complexes synthesis and properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Smart Drug Delivery of Ministry of Education, State Key Laboratory of Medical Neurobiology, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 200032, PR China

Department of interventional Radiology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, PR China

Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, PR China

Department of Neurosurgery, Shanghai First People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 201620, PR China

Funding

Ministry of Science and Technology of the People's Republic of China · Science and Technology Commission of Shanghai Municipality · National Natural Science Foundation of China · Shanghai Municipal Health and Family Planning Commission · Scientific Research Foundation for Talent Introduction, Fudan University

References (58)

Show source-provided references
1. 10.1001/archneur.65.7.87710.1001/archneur.65.7.877 ↗
2. 10.1056/NEJMra04366610.1056/NEJMra043666 ↗
3. 10.1056/NEJMra070812610.1056/NEJMra0708126 ↗
4. 10.1093/neuonc/nos27310.1093/neuonc/nos273 ↗
5. 10.1007/s12013-011-9265-610.1007/s12013-011-9265-6 ↗
6. 10.1038/nrc216710.1038/nrc2167 ↗
7. 10.1039/c0dt00292e10.1039/c0dt00292e ↗
8. 10.1039/C2CS35259A10.1039/C2CS35259A ↗
9. 10.1016/j.cbpa.2013.01.00410.1016/j.cbpa.2013.01.004 ↗
10. 10.1002/anie.20090365510.1002/anie.200903655 ↗
11. 10.1021/nn301148e10.1021/nn301148e ↗
12. 10.1021/ma201650310.1021/ma2016503 ↗
13. 10.1021/bm201729910.1021/bm2017299 ↗
14. 10.1016/j.addr.2011.10.00710.1016/j.addr.2011.10.007 ↗
15. 10.1038/nrd261410.1038/nrd2614 ↗
16. 10.1038/nnano.2008.3010.1038/nnano.2008.30 ↗
17. 10.1038/nnano.2011.16610.1038/nnano.2011.166 ↗
18. 10.1002/anie.20120527110.1002/anie.201205271 ↗
19. 10.1016/j.ijpharm.2016.10.03110.1016/j.ijpharm.2016.10.031 ↗
20. 10.3109/1061186X.2011.65172610.3109/1061186X.2011.651726 ↗
21. 10.1038/nbt117110.1038/nbt1171 ↗
22. 10.1021/bm070268j10.1021/bm070268j ↗
23. 10.1016/j.ijpharm.2013.07.01910.1016/j.ijpharm.2013.07.019 ↗
24. 10.1021/acsami.7b0350410.1021/acsami.7b03504 ↗
25. 10.1021/acsami.5b1173010.1021/acsami.5b11730 ↗
26. 10.1021/acsami.7b0368210.1021/acsami.7b03682 ↗
27. 10.2217/nnm.12.8610.2217/nnm.12.86 ↗
28. 10.1111/j.1600-0560.1998.tb01682.x10.1111/j.1600-0560.1998.tb01682.x ↗
29. 10.1016/j.npep.2005.03.00410.1016/j.npep.2005.03.004 ↗
30. 10.1038/nrd103310.1038/nrd1033 ↗
31. 10.1039/C5DT03433G10.1039/C5DT03433G ↗
32. 10.1002/adma.20110189910.1002/adma.201101899 ↗
33. 10.1021/am509146210.1021/am5091462 ↗
34. 10.1016/j.vph.2005.08.02910.1016/j.vph.2005.08.029 ↗
35. 10.1002/ijc.2843310.1002/ijc.28433 ↗
36. 10.1007/s11095-006-0068-110.1007/s11095-006-0068-1 ↗
37. 10.1002/adma.20160177810.1002/adma.201601778 ↗
38. 10.1016/j.jconrel.2016.11.00510.1016/j.jconrel.2016.11.005 ↗
39. 10.1038/bjc.2011.610.1038/bjc.2011.6 ↗
40. 10.1111/j.1349-7006.2009.01103.x10.1111/j.1349-7006.2009.01103.x ↗
41. 10.1188/04.CJON.263-26710.1188/04.CJON.263-267 ↗
42. 10.1016/j.jconrel.2011.08.01710.1016/j.jconrel.2011.08.017 ↗
43. 10.1073/pnas.141149911110.1073/pnas.1411499111 ↗
44. 10.1595/147106708X25598710.1595/147106708X255987 ↗
45. 10.1016/j.carbon.2011.11.04310.1016/j.carbon.2011.11.043 ↗
46. 10.1021/nn800551s10.1021/nn800551s ↗
47. 10.1021/nn202410f10.1021/nn202410f ↗
48. 10.1177/0271678X1663099110.1177/0271678X16630991 ↗
49. 10.1039/C5CS00030K10.1039/C5CS00030K ↗
50. 10.1016/j.ejpb.2008.08.02110.1016/j.ejpb.2008.08.021 ↗
51. 10.1016/j.biomaterials.2011.02.04410.1016/j.biomaterials.2011.02.044 ↗
52. 10.1038/nrd169110.1038/nrd1691 ↗
53. 10.1021/cr980421n10.1021/cr980421n ↗
54. 10.1002/jbm.82025121110.1002/jbm.820251211 ↗
55. 10.2165/00003495-200059004-0000210.2165/00003495-200059004-00002 ↗
56. 10.1016/j.addr.2014.01.01010.1016/j.addr.2014.01.010 ↗
57. 10.1039/C1CS15188F10.1039/C1CS15188F ↗
58. 10.2147/IJN.S59610.2147/IJN.S596 ↗